X-Ray Film Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

X-Ray Film Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

The X-ray film market is expected to register a CAGR of 5.4% over the forecast period 2021-2026. The continued adoption of traditional X-ray equipment in developing economies will drive the market in the forecast period.

• The growing occurrence of chronic diseases, coupled with the rising number of diagnostic imaging procedures and significant spending on healthcare across the world, has been instrumental in driving the medical X-ray market.
• X-ray techniques have been useful in the detection treatment of neurological problems, cancer, cardiac diseases, and bone-related problems. This has buoyed the adoption of X-ray equipment, and consequently the use of X-ray films.
• The strong consumer base in India and China, and the ageing population and the increasing demand for medical care have been instrumental in driving the market studied. However, over the forecast period, the establishment of new hospitals and medical facilities are expected to be in favour of the adoption of digital X-ray equipment, owing to the several benefits offered by them.
• Radiography in the medical field is undergoing a significant transition away from film and toward digital flat-panel detector technology(FDP), that has proved to be more affordable and efficient. With innovations, recent trends show that digital radiography over conventional systems is more effective in terms of image quality, further eliminating the need for X-ray films, chemicals, and darkroom setup, and thereby, improving the workflow and throughout.

• The demand for the diagnostic industry is expanding rapidly in developing economies. However, still, there are many major issues to be solved, which are test accuracy, quality, and cost, which is driving the demand for studies market in this segment.
• In developing economies, the major investment and essential technological developments are generated in the private sector, while in developed economies, like Europe, this is almost exclusive to the Public Sector. The public sector diagnostic imaging focuses on providing the highest possible coverage.
• For instance, in 2018, Dalian Wanda Group Co Ltd announced to invest USD10 billion in a health park in China. This investment is expected to be done after the government ease the norms for FDI in Chinese private healthcare sector.

• Asia-Pacific still relies on traditional x-ray solutions significantly. Due to the region’s increasing population and the number of patients suffering from ailments, who should be diagnosed or managed through the use of CT, the use of x-rays is on the rise. This growing pool of patients has led to high demand for medical imaging.
• In the Asia-Pacific region, hospitals play a crucial role in medical diagnostics. In China, the last recorded number of hospitals is on the rise, from 23,170 hospitals to 29,140 hospitals approximately, the National Bureau of Statistics of China reported an increase in the number of hospitals in the country.
• In addition to this, the move toward digital radiography is slow in the region when compared to other regions. This is because of the reliance on x-ray radiography to diagnose the ailment and diseases of the internal body parts. Thus, owing to the slower adoption of digital radiography, the market studied in APAC is expected to witness the fastest CAGR, over the forecast period.

The major players include Carestream, Sony, Fujifilm, Foma Bohemia, Konica Minolta, Flow Dental, and others. There is moderately intense competition in the market since the innovation is at a slower pace as of now.

• January 2018 - Carestream healthcare displayed its medical imaging workflow portfolio at the 71st annual conference of the Indian Radiology and Imaging Association, Mumbai, India. The company displayed products like Managed Print Solutions (MPS), which automates the ordering, purchasing, and stocking of x-ray films.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support